Navigation Links
Bradmer to present poster on progression free survival and overall survival data from Neuradiab(TM) Phase II trials at Society for Neuro-Oncology Meeting
Date:11/19/2008

TSX: BMR

TORONTO, Nov. 19 /PRNewswire-FirstCall/ - Bradmer Pharmaceuticals Inc., a biopharmaceutical company dedicated to the development and commercialization of cancer therapies, announced today that it will be presenting an abstract on the Phase II data from Neuradiab(TM) at the Society for Neuro-Oncology's (SNO) 13th Annual Scientific Meeting. The abstract, outlining the results from two previously conducted Phase II trials, is titled An update on the effects of Neuradiab(TM) on Patients with Newly Diagnosed Glioblastoma Multiforme (GBM). The SNO meeting is being held in Lake Las Vegas, Nevada from November 20th to 23rd at the Loews Lake Las Vegas Resort. The abstract will be presented between 5:00pm and 7:00pm on Saturday, November 22nd during the Meeting's General Poster Session.

The abstract describes the response of newly diagnosed GBM patients treated with Neuradiab as an adjunct to the current standard of care, consisting of surgery, temozolomide and external radiation. A recent analysis of study 01128 after 231 weeks of median follow-up (n = 14) showed a median overall survival of 102.1 weeks, and a median progression free survival of 77.3 weeks, or 17.8 months. Study 05018 showed a median overall survival of 107.7 weeks and a progression free survival of 74.6 weeks, or 17.2 months, (n = 5). The increase in overall survival and progression free survival will be presented in comparison to historical data from other third-party published trials. A copy of the abstract will be posted on the Company's website on November 23rd at www.bradmerpharma.com.

The analysis of the 231 week follow-up data was conducted after the submission and publication of the studies in Neuro-Oncology, reference:

Reardon et al., J Neuro-Oncology, Doc. D06-00199, February 20, 2008 or

http://neuro-oncolog
'/>"/>

SOURCE Bradmer Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Bradmer announces 2008 third quarter operational and financial results
2. Bradmer to present at Rodman & Renshaw Healthcare Conference
3. Bradmer receives FDA approval to proceed with Phase III clinical trial
4. Bradmer announces 2008 first quarter operational and financial results
5. Bradmer announces new additions to management team
6. Bradmer announces 2007 fourth quarter and fiscal year operational and financial results
7. Notice of Bradmer Pharmaceuticals Conference Call
8. Bradmer announces Phase II results published in newly diagnosed glioblastoma which demonstrate improved survival and support upcoming Phase III study
9. Bradmer to present at the 10th Annual BIO CEO & Investor Conference
10. Bradmer announces additions to Scientific Advisory Board
11. Bradmer Medical Isotope Supply For Phase III Trial Secure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... FL (PRWEB) , ... July 30, 2015 , ... Using ... eradicate suicide and teach people more effective ways to prevent and manage major depression. ... to react fast enough, so people fall through the cracks and die needlessly everyday,” ...
(Date:7/30/2015)... Mequon, Wisconsin (PRWEB) , ... July 30, 2015 , ... ... rejuvenation. Kybella is a nonsurgical treatment designed specifically for the elimination ... is one of the first locations in the state of Wisconsin to offer this ...
(Date:7/30/2015)... ... July 30, 2015 , ... The Tisch ... Institute Designation , The Tisch Cancer Institute (TCI) at the Icahn School of ... center. TCI joins an elite group of 69 cancer institutions nationwide that have ...
(Date:7/30/2015)... ... July 30, 2015 , ... Author Dr. Raul Llanos seeks ... in his new self-help book, “ Consciously Healing our Webs of Health, Wellbeing, Success, ... message: “If we take responsibility for ourselves, we can create better realities.” His book ...
(Date:7/30/2015)... Washington, DC (PRWEB) , ... July 30, 2015 ... ... in a fight with its Medicare administrative contractor (MAC) over submitted claims for ... rejected. Calling it a challenge to program integrity, Becky Dennis, a nurse auditor ...
Breaking Medicine News(10 mins):Health News:Happiness Expert Develops Pioneering Online Tools for Sufferers of Major Depression, and Who may be Suicidal 2Health News:Happiness Expert Develops Pioneering Online Tools for Sufferers of Major Depression, and Who may be Suicidal 3Health News:Quintessa MedSpa Offers Nonsurgical Double-chin Elimination 2Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 2Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 3Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 4Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 5Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 6Health News:New book by Dr. Raul Llanos: ‘The power to change is within’ 2Health News:New book by Dr. Raul Llanos: ‘The power to change is within’ 3Health News:Hospital Details Fight for Bariatric Surgery Reimbursement in AIS Newsletter 2Health News:Hospital Details Fight for Bariatric Surgery Reimbursement in AIS Newsletter 3
... Help Kids Worldwide, NEW YORK, Feb. 4 ... are being asked to submit creative,drawings for the 2008 ... One winner will be chosen from thousands of,entries and ... UNICEF,holiday greeting card, sold exclusively at Pier 1 Imports ...
... YORK, February 4, 2008 The Juvenile Diabetes ... of type 1 diabetes research, announced today that ... company based in Winston-Salem, N.C. that focuses on ... Through its Industry Discovery and Development Partnership Program, ...
... Feb. 4 Renowned esthetician, Karen,Dunlap, has developed ... recognized as the number-one most nutritious and powerful ... the dots between science and,nature, Dunlap discovered that ... -- magnifies its benefits. Her new signature facial, ...
... and 4 percent of former illicit drug users ... year following an organ transplant. These results are ... a journal by John Wiley & Sons. The ... ( http://www.interscience.wiley.com/journal/livertransplantation ). , Substance abuse can lead ...
... 2008 Contrary to previous research, older adults who use ... reduced risk of developing dementia or Alzheimers disease. This is ... the American Geriatrics Society that tracked patients using vitamin E ... than 5 years. The study also finds that the combined ...
... connecting patients and caregivers offers tips to families, ... ... helpful, CHICAGO, Feb. 4 What do you say, what ... or suffering from a serious,disease? To kick-off National Patient Recognition Week, ...
Cached Medicine News:Health News:Budding Young Artists Invited to Compete in 17th Annual Pier 1 Imports/UNICEF Greeting Card Contest 2Health News:Budding Young Artists Invited to Compete in 17th Annual Pier 1 Imports/UNICEF Greeting Card Contest 3Health News:JDRF partners with Plureon to explore generating insulin-producing cells from adult stem cells 2Health News:Breakthrough 'Acai Berry Anti-Aging Facial' Applies Benefits of Nature's Super-Food to the Skin 2Health News:Former substance abusers rarely relapse after organ transplantation 2Health News:Vitamin E or C does not reduce risk of dementia or Alzheimer's 2Health News:It's National Patient Recognition Week - Here's How You Can Do Something Special for Someone Facing Illness 2Health News:It's National Patient Recognition Week - Here's How You Can Do Something Special for Someone Facing Illness 3
(Date:7/29/2015)... Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Mutation Test v2 for Premarket Approval (PMA) to ... a companion diagnostic test for AZD9291, an AstraZeneca ... with an acquired resistant mutation.  ... adenocarcinoma with tumor containing an EGFR sensitizing mutation ...
(Date:7/29/2015)... 2015 Dignity Health Saint Francis Memorial Hospital ... services of the hospital,s former Total Joint Center and ... expanding services to include shoulder orthopedic care. The new ... Memorial Hospital at 1199 Bush Street. ... aimed at providing a continuum of orthopedic care delivered ...
(Date:7/29/2015)... , July 29, 2015  Unilife Corporation ("Unilife" ... UNS), a developer, manufacturer and supplier of injectable drug ... financing strategy that provides the Company with flexibility and ... Unilife has signed an equity purchase agreement for ... LLC ("LPC"), a Chicago -based institutional ...
Breaking Medicine Technology:Roche submits filing to FDA for companion diagnostic for non-small cell lung cancer drug therapy 2Roche submits filing to FDA for companion diagnostic for non-small cell lung cancer drug therapy 3Saint Francis Memorial Hospital Orthopedic Institute Offers Comprehensive Orthopedic Care in One Location 2Unilife Announces Multifaceted Financing Strategy 2Unilife Announces Multifaceted Financing Strategy 3Unilife Announces Multifaceted Financing Strategy 4Unilife Announces Multifaceted Financing Strategy 5
... is a super-light polypropylene mesh which offers ... is reduced considerably. Optilene Mesh LP is ... hernia repair procedures. It perfectly conforms,to anatomical ... Mesh LP adapts to the movements of ...
... Mesh LP is a lightweight polypropylene ... and considerably reduced,foreign body reaction. The ... pain. It perfectly conforms to,anatomical structures. ... Mesh LP adapts to the movements ...
... The Celsius Control System ... that can safely,and rapidly lower ... chosen target temperature and,rewarm patients ... Control System consists of an ...
... coronary artery surgery is the latest revolution ... being embraced world-wide by increasing numbers of ... but reduced mortality, stroke, and bleeding as ... A cardiac stabilizer is mandatory for this ...
Medicine Products: